3Nagao T,Sugane I,Ishida Y,et al. Basal cell adenocarcinoma of the salivary glands:Comparison with basal cell adcnomabrough assessment of cell prolifer-ation.apoptosis and expression of p53 and bcl-2 .Cancer, 1998,82(3):439.
4Gallo O,Franchi A,Bianch S,et al.p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer,1995,75(8):2037.
5Deguchi H,Hamano H,Hayashi Y.C-myc、Ras21 and p53 expression in pleomrphic adenoma and its malignant form of the human salivary glands. Acta Pathologica Japonica, 1993,43(7-8):413.
6Wen S,Tsuji T, Li X,et al.Immunohistochemical detection of p53 protein and proliferating cell nuclear antigen (PCNA) in salivary gland tumors. Oncology Reports, 1995,2:233.
7Chen PL, Chen YM,Bookstein R,et al. Genetic mechanisms of tumor suppression by the human p53 gene. Science, 1990,250(4987):1576.
8Cai DW,Mukhopadhyay T,Liu Y,et al. Stable expression of the wildtype p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum-Gene-Ther, 1993,4(5):617.
9Liu TJ,Zhang WW,Taylor DL,et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer- -Res,1994,54(14):3662.
10Fujiwara T, Gai DW,Georges RN,et al. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model [see comments]. J-Natl-Cancer-Inst, 1994,86(19): 1458.
